Abstract

780P Role of BRCA1 promotor methylation in homologous recombination deficiency (HRD) in high-grade ovarian cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Correlation of BRCA and HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer in the age of PARPi maintenance therapy (187)
Kelly Rangel ... Nicole Fleming
Gynecologic Oncology | VOL. 166
Kelly Rangel, et. al.Kelly Rangel ... Nicole Fleming
01 Aug 2022
Distribution of homologous recombination deficiency (HRD) and BRCA mutations (m) detected by HRD-One test among Brazilian patients (pts) with newly diagnosed advanced epithelial ovarian, fallopian tube, or peritoneal cancer.
Fernanda Milanezi ... Mariana Scaranti
Journal of Clinical Oncology | VOL. 40
Fernanda Milanezi, et. al.Fernanda Milanezi ... Mariana Scaranti
01 Jun 2022
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study
...
International Journal of Gynecologic Cancer | VOL. 33
, et. al. ...
18 Apr 2023
Correlation of HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer.
Tyler Hilton ... Shannon Neville Westin
Journal of Clinical Oncology | VOL. 39
Tyler Hilton, et. al.Tyler Hilton ... Shannon Neville Westin
20 May 2021
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3
M.P Goetz ... S.R.D Johnston
Annals of Oncology | VOL. -
M.P Goetz, et. al.M.P Goetz ... S.R.D Johnston
01 May 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: ‘ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe’, by A. Bayle et al.
J García-Foncillas ... A Stenzinger
Annals of Oncology | VOL. -
J García-Foncillas, et. al.J García-Foncillas ... A Stenzinger
01 May 2024
Re: Parker CC, Petersen PM, Cook AD, et al. Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial [NCT00541047]. Ann Oncol. 2024 Apr 5:S0923-7534(24)00105-4
Elio Mazzone ... Francesco Montorsi
Annals of Oncology | VOL. -
Elio Mazzone, et. al.Elio Mazzone ... Francesco Montorsi
01 May 2024
Table of Contents
-
Annals of Oncology | VOL. 35
--
01 May 2024
View more papers